Association of HIV infection with extrapulmonary tuberculosis: a systematic review

Affiliations.

  • 1 Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • 2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • PMID: 27830524
  • PMCID: PMC5303538
  • DOI: 10.1007/s15010-016-0960-5

Purpose: HIV/AIDS is a known risk factor for the development of pulmonary tuberculosis (PTB). However, the association is less clear between HIV and extrapulmonary tuberculosis (EPTB). We conducted a systematic review to determine the association between HIV and EPTB.

Methods: We searched the electronic databases Medline, Embase, and relevant conference literature using defined search terms for EPTB and HIV. Only publications in English and only studies reporting adjusted estimates were included, while our search criteria did not include restriction by age or geographic location of study participants. Qualitative and quantitative analyses (including I 2 test for heterogeneity) were performed.

Results: Sixteen studies (15 cross-sectional and 1 case-control) conducted from 1984 to 2016 were included in the final analyses after screening 5163 articles and conference abstracts. Our qualitative analysis showed heterogeneity in study design and study population characteristics along with a medium/high risk of bias in the majority of studies. While most of the individual studies showed increased odds of EPTB compared with PTB among HIV-infected individuals, we did not provide an overall pooled estimate, as the I 2 value was high at 93% for the cross-sectional studies.

Conclusions: While an association between HIV and EPTB is observed in most individual studies, the high heterogeneity and risk of bias in these studies highlight the need for further well-designed prospective cohort studies to assess the true risk of EPTB in the HIV-infected patient population.

Keywords: EPTB; HIV; Pulmonary TB; Systematic review; TB.

Publication types

  • Systematic Review
  • Child, Preschool
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • Infant, Newborn
  • Middle Aged
  • Risk Factors
  • Tuberculosis* / complications
  • Tuberculosis* / epidemiology
  • Young Adult

Grants and funding

  • K99 HD089753/HD/NICHD NIH HHS/United States

U.S. flag

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

  • Publications
  • Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

  • Advanced Search
  • Journal List
  • Epidemiol Health

Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study

Leila molaeipoor.

1 Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

Jalal Poorolajal

2 Research Center for Health Sciences and Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

Minoo Mohraz

3 Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Science, Tehran, Iran

Nader Esmailnasab

4 Kurdistan Research Center for Social Determinants of Health, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

OBJECTIVES:

The human immunodeficiency virus (HIV) and Mycobacterium tuberculosis co-infection is a major global challenge. It is not clear why some HIV-positive people are co-infected with tuberculosis (TB) while others are not. This study addressed that question.

This case-control study was conducted in Tehran, Iran in June 2004, enrolling 2,388 HIV-positive people. Cases were selected from those who were co-infected with TB and controls from those without TB. Multiple logistic regression analysis was performed to assess the association between M. tuberculosis /HIV co-infection and several predictors. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated.

In this study, 241 cases were compared with 2,147 controls. Sex, age, marital status, educational level, imprisonment, smoking, narcotic use, route of HIV transmission, previous TB infection, isoniazid preventive therapy (IPT), antiretroviral therapy (ART), and low CD4 count (<350 cells/mm 3 ) were independently associated with M. tuberculosis /HIV co-infection (p<0.001). However, after adjusting for all other variables in the model, only the association between M. tuberculosis /HIV co-infection and the following predictors remained statistically significant: imprisonment (odds ratio [OR], 3.82; 95% confidence interval [CI], 2.11-6.90), previous TB infection (OR, 5.54; 95% CI, 1.99-15.39), IPT (OR, 0.13; 95% CI, 0.06-0.31), ART (OR, 1.81; 95% CI, 1.26-2.61), and CD4 count <350 cells/mm 3 (OR, 2.34; 95% CI, 1.36-4.02).

CONCLUSIONS:

Several predictors are associated with M. tuberculosis /HIV co-infection, but only a few indicators were significantly associated with M. tuberculosis /HIV co-infection. It is estimated that a number of predictors of M. tuberculosis /HIV co-infection remain unknown and require further investigation.

INTRODUCTION

To halt and reverse the tuberculosis (TB) epidemic by 2015 is the sixth Millennium Development Goals [ 1 ]. The human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and Mycobacterium tuberculosis co-infection is one of the major global challenges in the control of TB [ 2 ]. The risk of developing TB is 20-37 times greater in HIV-positive people than HIV-negative people [ 3 ]. TB is the leading preventable cause of death among HIV-infected people [ 2 ] and is responsible for more than 25% of deaths in people living with HIV [ 3 ]. TB increases the risk of HIV-related mortality by 4.5fold [ 4 ]. In 2012, there were an estimated 8.6 million new cases of TB and 1.3 million died from TB. Over 95% of TB cases and deaths occur in low- and middle-income countries [ 5 ].

There are several conditions associated with increased risk of M. tuberculosis /HIV co-infection. Men living with HIV are more likely to be infected with TB than women [ 6 - 8 ]. The TB prevalence shows a bimodal distribution at the extremes of age [ 9 ]. The active TB is more common in immunosuppressed people [ 5 ]. People who live in close contact with people who have active TB are more likely to be infected with TB [ 10 ]. In HIV-positive people, the probability of TB increases as the CD4 cell count decreases [ 7 , 8 , 10 , 11 ]. Tobacco use is substantially associated with increased risk of disease and mortality caused by TB [ 5 ]. Anemia and iron deficiency disorders are associated with an increased risk of TB [ 12 , 13 ]. Low body mass index can increase the probability of the TB infection [ 14 , 15 ].

Several studies have been conducted worldwide to assess the predictors of M. tuberculosis /HIV co-infection [ 9 , 11 - 15 ]. However, the prognostic factors behind the breakdown in immune defenses associated with TB infection in people living with HIV are not fully understood. It is unclear why some HIV-positive people are co-infected with TB while others are not. Until reliable information on predictors of TB is collected, it will remain difficult to design effective preventive intervention strategies to control TB in HIV-infected people. This case-control study was conducted in a large population in Iran to determine the main prognostic factors associated with HIV and M. tuberculosis co-infection.

MATERIALS AND METHODS

This case-control study was conducted in the megacity of Tehran, Iran in June 2004. The Research Council of Hamadan University of Medical Sciences approved the study. The study population was HIV-positive people with or without TB who had a medical record in one of two Behavioral Diseases Counseling Centers, the Imam Khomeini and Zamzam Centers. These centers provide several health services, such as education, counseling, self-care, prevention, treatment, and harm reduction, to people who are at high risk of HIV and sexually transmitted diseases [ 16 ].

The cases were selected from HIV-positive people co-infected with TB aged equal to or greater than 18 years irrespective of sex and date of diagnosis, whether or not they had developed AIDS. The additional data on TB infection were extracted from the Centers for Disease Control and Prevention. The controls were selected from HIV-positive people without TB. The controls were selected from a control group from the same database from which the cases were selected in order to make the study base of the two groups the same.

The data collection was done using a checklist of items which was developed according to the information documented in the medical records including demographic information (age, sex, marital status, and educational level), behavioral information (narcotic/alcohol abuse, smoking, and imprisonment), and additional information such as co-infection with hepatitis C virus (HCV), history of previous TB infection, anti-TB prophylaxis, antiretroviral therapy (ART), and CD4 cell count per cubic millimeter. The people with school education (less than or equal to 12 years education) was considered as less educated and those with university education (more than 12 years education) were considered as highly educated.

An HIV-positive subject was defined as an individual with HIV infection irrespective of clinical stage confirmed by laboratory criteria according to country definitions and requirements [ 17 ]. In the Islamic Republic of Iran, a case of HIV is defined as a positive result for HIV antibody by two sequential enzyme-linked immunosorbent assay tests confirmed by a western blot test [ 18 ]. A case of AIDS was defined as a presumptive or definitive diagnosis of stage 3 or 4 conditions and/or a CD4 count less than 350 cells/mm 3 of blood in an HIV-infected subject [ 17 ].

Active TB was defined as a disease that is caused by M. tuberculosis in any part of the body and that is in an active state. In the Islamic Republic of Iran, a patient with two positive sputum smears or one positive sputum smear plus a positive sputum culture or a chest X-ray demonstrating pulmonary TB is considered to have sputum-positive pulmonary TB. A patient with two negative sputum smears but with a positive sputum culture or with signs and symptoms of pulmonary TB not responding to a two-week broad-spectrum antibiotic treatment is considered to have sputum-negative pulmonary TB. Extra-pulmonary TB is diagnosed with bacteriological evidence (positive culture) and pathological findings (caseous necrosis) [ 19 ].

Adults and adolescents living with HIV who are unlikely to have active TB, based on a clinical algorithm screening, should receive isoniazid preventive therapy (IPT) for at least 6 months (10 mg/kg/d) as part of a comprehensive package of HIV prevention and care services [ 2 ]. In the Islamic Republic of Iran, after excluding active TB, HIV-positive patients with the following criteria will receive IPT: (a) TB skin test (purified protein derivative skin test) equal to or greater than 5 mm; (b) close contact with an infectious TB case; and (c) chest X-ray findings suggestive of fibrotic lesions consistent with TB [ 16 ].

Logistic regression analysis was performed to determine the factors predictive of M. tuberculosis /HIV co-infection. To control the effect of potential confounding factors, a backward stepwise adjusted analysis was performed to fit the data well and to exclude unnecessary variables from the model. For this purpose, we started with the full model and then excluded variables one at a time, while using the likelihood ratio test to check whether the reduced model or the full model fitted the data significantly well. Crude and adjusted odds ratios (ORs) were reported to address the effect of predictors associated with M. tuberculosis /HIV co-infection. All statistical analyses were performed at a significance level of 0.05 using Stata version 11 (StataCorp, College Station, TX, USA).

We identified 2,519 patients; 25 were ineligible, 21 had medical records in both centers, and 85 were aged below 18 years. The analysis was based on data from the remaining 2,388 people (241 cases and 2,147 controls), of which 1,889 were men and 499 were women. The mean standard deviation age of the patients was 34.99 (8.84) years and ranged from 18 to 74 years.

Results from the bivariate logistic regression analysis of predictors associated with M. tuberculosis /HIV co-infection are given in Table 1 . There was a highly significant association between male sex and M. tuberculosis /HIV co-infection. The risk of TB increased significantly with age. Compared to married people, the single, divorced, or widowed people were at higher risk of infection with TB. The risk of co-infection with TB was higher in highly educated individuals than in those with less education. Imprisonment, smoking, and narcotic use were associated with increased the risk of M. tuberculosis /HIV co-infection significantly. Compared to the sexual route of infection, intravenous drug use and multiple routes of HIV transmission were associated with an increased risk of TB. Heterosexuality increased the risk of TB more than other modes of sexual transmission. History of previous TB infection was the strongest risk factor for M. tuberculosis /HIV co-infection. The HIV-positive individuals who were co-infected with HCV had a greater risk of co-infection with TB as well. Preventive treatment with isoniazid decreased the risk of TB to less than one-fifth in HIV-positive people. The CD4 cell count less than 350 cells/mm 3 was associated with an increased risk of TB so that the lower the CD4 cell count, the higher the risk of M. tuberculosis /HIV co-infection.

Results from the bivariate logistic regression analysis of binary and continuous predictors of M. tuberculosis /HIV co-infection using unadjusted odds ratios (ORs)

HIV, human immunodeficiency virus;TB, tuberculosis; CI, confidence interval.

Results from the multivariate logistic regression analysis of predictors associated with M. tuberculosis /HIV co-infection are given in Table 2 . The pseudo R 2 statistic, which assesses the predictive strength of the logistic regression, was 0.1444. In order to control the effect of potential confounding and to fit the data well, a backward stepwise adjusted analysis was performed, and the unnecessary variables were excluded from the model. Eight variables remained in the final model, of which only five predictive factors were strongly associated with M. tuberculosis /HIV co-infection including imprisonment, previous TB infection, IPT, ART, and reduced CD4 cell count.

Results from the multivariate logistic regression analysis of binary and continuous predictors of M. tuberculosis/HIV co-infection using odds ratios (ORs) adjusted for all other variables in the model (pseudo R 2 =0.144)

HIV, human immunodeficiency virus; TB, tuberculosis; CI, confidence interval.

Reducing the TB pandemic by 2015 is the sixth Millennium Development Goals [ 1 ]. To better understand the risk factors of TB infection in people who live with HIV, the association between several predictors and M. tuberculosis /HIV co-infection was investigated. We found that sex, age, marital status, educational level, smoking, narcotic use, and route of HIV transmission were independently associated with increased risk of TB infection in people living with HIV. However, the multivariate analysis revealed no association between these variables and M. tuberculosis /HIV co-infection. On the other hand, there was a strong association between M. tuberculosis /HIV co-infection and imprisonment, previous TB infection, IPT, ART, and CD4 cell count less than 350 cells/mm 3 .

Current studies have reported that the risk of M. tuberculosis /HIV co-infection increases with male sex [ 6 - 8 ], age [ 9 ], and tobacco use [ 5 ], as was the case in our study. However, multivariate analysis revealed that the associations between M. tuberculosis /HIV co-infection and male sex, age, and smoking were confounded by other variables. According to our results, age and smoking do not increase the risk of TB infection in HIV-positive people. On the other hand, current studies have shown that the risk M. tuberculosis /HIV co-infection is higher among people who are immunosuppressed [ 5 ] or live in close contact with people who have active TB [ 10 ] or have a CD4 cell count below 200 cells/mm 3 [ 10 , 11 ]. Our results were consistent with these findings. Multivariate analysis indicated that previous TB infection and CD4 cell count less than 350 cells/mm 3 substantially increased the risk of TB in people living with HIV.

We noted that previous imprisonment was related to an increased risk of M. tuberculosis /HIV co-infection. Inmates are at a high risk of TB infections because they generally receive minimal preventive care and access to treatment facilities [ 20 ]. In addition, inadequate health services may increase the risk of unmanageable HIV and TB epidemics in prisons [ 21 , 22 ].

According to our results, IPT was the most efficient intervention to prevent TB in people who live with HIV and could reduce the risk of TB by 87%. This finding is consistent with current evidence. Current studies have shown that IPT can significantly reduce the risk of TB in people living with HIV in various settings, especially in TB-endemic settings [ 23 , 24 ].

We reported an inverse association between the prevalence of M. tuberculosis /HIV co-infection and CD4 cell count, such that the risk of co-infection increased as the CD4 cell count decreased. This finding is consistent with the current evidence [ 10 , 11 ]. On the other hand, we found that HIV-positive people who received ART were at a higher risk of M. tuberculosis /HIV co-infection. The reason is straightforward. ART was initiated for the HIV patients when they developed stage 3 or 4 characteristics or their CD4 cell count decreased to below 350 cells/μL. Both of these conditions can increase the risk of M. tuberculosis /HIV co-infection [ 7 , 8 , 10 , 11 ].

According to our results, high risk behaviors were more common in cases than in controls. These included imprisonment (80.08% vs. 60.92%), narcotic use (66.80% vs. 51.47%), alcohol use (6.36% vs. 4.15%), smoking (69.05% vs. 55.13%), and previous history of TB infection (4.15% vs. 0.75%). These high risk behaviors might predispose HIV patients to TB infection.

This study had a few limitations. First, this study was performed on data recorded at the Behavioral Diseases Counseling Centers. The quality and accuracy of the associations reported in this study primarily depend on the quality of the recorded data, but we were unable to verify the accuracy of the data. This raises the possibility of information bias. Second, despite several predictors assessed in this study, the value of the pseudo R2 statistic that indicates the predictive strength of the logistic regression was low. This demonstrates that there are still many unknown factors that affect the incidence of TB in people with HIV. Despite its limitations, this study was conducted on a large dataset in the megacity of Tehran, which comprises about 20% of the Iranian population. Therefore, the results of this study may be generalized to a majority of the Iranian HIV-infected population. Furthermore, the effects of several predictive factors on M. tuberculosis /HIV co-infection were evident in a middle income country. Such information may be useful for establishing preventive measures.

According to the results of this study, despite the fact that several modifiable and non-modifiable predictors were independently associated with M. tuberculosis /HIV co-infection, it was evident that only a few indicators such as imprisonment, previous TB infection, IPT, ART, and low CD4 cell count (<350 cells/ mm 3 ) had a significant effect on M. tuberculosis /HIV co-infection. In addition, there are still several unknown predictors that affect the association between HIV and TB and require further investigation.

Acknowledgments

The paper was part of an MSc thesis in Epidemiology. We would like to express our appreciation to the Vice Chancellor of Education for technical support and the Vice Chancellor of Research and Technology of Hamadan University of Medical Sciences for financial support of this work. We also thank the staff members and managers of the Imam Khomeini and Zamzam Behavioral Diseases Counseling Centers for their collaboration with this study.

The author has no conflicts of interest to declare for this study.

IMAGES

  1. Buy Comparing outcomes: Pulmonary tuberculosis and HIV: A case-control

    hesi pn case study hiv and tuberculosis

  2. HIV and TB coinfection

    hesi pn case study hiv and tuberculosis

  3. Case Study Of Hiv Aids In South Africa

    hesi pn case study hiv and tuberculosis

  4. (PDF) CASE STUDY ON PULMONARY TUBERCULOSIS

    hesi pn case study hiv and tuberculosis

  5. (PDF) HIV-associated tuberculosis: Relationship between disease

    hesi pn case study hiv and tuberculosis

  6. (PDF) HIV-ASSOCIATED TUBERCULOSIS : Case Report

    hesi pn case study hiv and tuberculosis

VIDEO

  1. First Sign of HIV in Man

  2. Webinar Nasional: Mengelola HIV dengan Efektif: Memahami Pemeriksaan Kesehatan Secara Komprehensi

  3. Empowering Communities through Arts Education

  4. The Origin of HIV AIDS: Bushmeat Hunting Explained #HIV

  5. Tuberculosis renal

  6. סיפורי אבא גברהנא: אהבה- የፍቅር ታሪክ

COMMENTS

  1. PN Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) HESI Case Study

    The HCP prescribes an IV bolus of 1000 mL normal saline to be administered over 6 hours. The PN notifies the charge nurse, and the RN initiates placement of a 20 gauge INT in Matthew's left forearm. With a tubing drop factor of 10 gtts/mL, how many drops/minute will the RN administer the bolus? 28.

  2. HESI Case Study: HIV & TB Flashcards

    What statement shows that Jeff understands why he is at risk for TB? My T-helper cells are diminished from HIV and those cells are needed to fight HIV. How should the nurse preceptor respond? This is not always true. 5mm induration is considered positive in an HIV positive client. How should the nurse respond?

  3. HIV & TB HESI CASE STUDY Flashcards

    HESI: HIV and Tuberculosis and Rationale. 25 terms. K_Copeland5. Preview. exam 2 scenario examples . 53 terms. yiselleg. Preview. FON Chapter 18: Planning Nursing Care ... Preview. Cirrhosis HESI Case Study (evolve) 25 terms. mblopez2021. Preview. HESI HIV and TB Case Study. 25 terms. Eliza_Foster_ Preview. NUR337: MIDTERM EXAM. 367 terms ...

  4. Diagnosis and treatment of tuberculosis in adults with HIV

    1. Introduction. Tuberculosis (TB) is the second leading cause of death from infectious diseases after coronavirus disease 2019 (COVID-19). In 2020, there were an estimated 9.9 million new cases of TB and ≈1.5 million deaths from TB worldwide. [] Human immunodeficiency virus (HIV) can increase the risk of active TB up to 26 times, which leads to atypical clinical manifestations of the latter ...

  5. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected

    Second, although isoniazid preventive therapy was known to decrease the rate of, and mortality from, tuberculosis among HIV-infected adults living in areas with a high burden of tuberculosis, 32 ...

  6. PDF HESI Case Studies Best Practices

    Have each group report to the class what they found to be the most interesting or valuable. Consider posing "What if" questions to expand on the case outcome. Have students write an SBAR of the case study and share with their peer(s). Discuss what needs to be charted in an EHR for this case study and document in an EHR as available.

  7. Latent Tuberculosis among Human Immunodeficiency Virus (HIV ...

    Background: Tuberculosis is the most common opportunistic infection affecting HIV-infected individuals and it remains the most common cause of death in patients with AIDS. Detection of latent tuberculosis and treatment largely prevents the development of active disease. Objective: This study was to determine the prevalence and factors associated with latent TB in HIV-positive patients.

  8. Mycobacterium tuberculosis infection in a HIV-positive patient

    Mycobacterium tuberculosis (MTB) and human immunodeficiency virus (HIV) coinfection remains a global public health challenge. We report a 40 year old African American male who is a known HIV-positive patient, non-compliant with his antiretrovirals and developed pulmonary tuberculosis. His chief complaints were chronic cough, fever, night sweats ...

  9. HIV and Tuberculosis HESI Case Study (docx)

    Health-science document from Toronto Metropolitan University, 2 pages, HIV and Tuberculosis HIV Signs and Symptoms: - Fatigue - Productive cough - Weight loss - Tuberculosis is often spread through the air d/t infectious droplets UAP Delegation - Cannot teach - Cannot assess - Can tell patient about when a specimen needs to.

  10. HIV infection and multidrug resistant tuberculosis: a systematic review

    Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a serious threat to global efforts to combat tuberculosis. Inconsistent findings on the association between HIV infection and MDR-TB were present in many studies. We aimed to review existing data on the relationship between HIV infection and MDR-TB systematically to assess ...

  11. NU372 Week 2 HESI Case Study: Human Immunodeficiency Virus (HIV) and

    Client's significant other arrives. Client wants to know why a mask is necessary for people entering their room. What teaching should the nurse implement? o Explain the use of a private room and mobile high-efficiency particle filters placed in the room. o Explain that the tuberculosis (TB) organism is most often spread through the air. o Tell client that tuberculosis (TB) will not be spread ...

  12. Tuberculosis in Patients with Human Immunodeficiency Virus Infection

    Tuberculosis remains an important problem in patients with human immunodeficiency virus (HIV) infection in the United States, with an estimated 6000 to 9000 new cases annually.1 The case rates are ...

  13. Pathogenesis of Human Immunodeficiency Virus and Mycobacterium ...

    Tuberculosis (TB) among patients with human immunodeficiency virus (HIV) is a major global health burden and contributes to a high mortality rate due to HIV-mediated immunosuppression and subsequent susceptibility to TB. It is imperative to understand the pathogenesis of the association between HIV …

  14. Hesi Case Study HIV and TB Flashcards

    Take client's blood pressure to assess for postural hypotension. The HCP is notified of client's physical exam findings indicating possible dehydration and vital signs, including a blood pressure of 100/50. It is determined that client could use a bolus of IV fluids. The HCP prescribes 1000 mL of sodium chloride 0.45% to run over 6 hours.

  15. HIV-TB co-infection with clinical presentation, diagnosis, treatment

    Introduction. Tuberculosis is without a doubt the most common OI and causes majority of deaths in HIV infected individuals.[1,2,3,4,5] According to World Health Organization (WHO) estimates in 2017, 10 million got infected with TB out of which 1.6 million succumbed, of which 0.3 million was accounted by those people diagnosed with HIV, although the rate has decreased when compared with 2005 ...

  16. Association of HIV infection with extrapulmonary tuberculosis: a

    However, the association is less clear between HIV and extrapulmonary tuberculosis (EPTB). We conducted a systematic review to determine the association between HIV and EPTB. ... (15 cross-sectional and 1 case-control) conducted from 1984 to 2016 were included in the final analyses after screening 5163 articles and conference abstracts. Our ...

  17. HESI Case Study Playerhiv

    Med Surg. C57 - ch 57 test bank. Med Surg. C64 - ch 64 test bank. Med Surg. C32 - ch 32 test bank. Med Surg. hesi case study 7:19 pm hesi case study player collapse pn human immunodeficiency virus (hiv) and tuberculosis (tb) case study 54mins meet the client section.

  18. Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the

    Dr. Robert H. Goldstein (Medicine): A 55-year-old man with Crohn's disease and a new diagnosis of human immunodeficiency virus type 1 (HIV-1) infection was seen in the infectious diseases clinic ...

  19. NU372 HESI Case Study: HIV + TB Flashcards

    a) Explain the use of a private room and mobile high-efficiency particle filters placed in the room. b) Explain that the tuberculosis (TB) organism is most often spread through the air. c) Tell client that tuberculosis (TB) will not be spread to others, and everything will be okay if the mask is worn. d) Tell client that masks are required for ...

  20. HESI HIV

    Client's significant other may stay in the room, but they should wear a mask to help decrease the possibility of contracting the TB organism. "They may stay, but they need to wear a mask." Exit. HESI Case Study 10:45 pm hesi case study player collapse human immunodeficiency and tuberculosis case study 50mins meet the client section section section.

  21. HIV-associated tuberculosis

    Epidemiology of HIV-associated TB. TB is the leading cause of HIV-associated hospitalization and death among adults and children living with HIV worldwide, 4 and accounted for a third (208,000) of the estimated 690,000 HIV-related deaths globally in 2019, 81% of these deaths occurring in the African region. 3 A systematic review of postmortem studies from resource-limited settings found that ...

  22. HESI RN Case Study: HIV/TB Flashcards

    The most significant adverse effect is optic neuritis. HESI RN Case Study: HIV/TB. 2.5 (6 reviews) Raymond Malone, age 45 years admitted from his healthcare provider's office (HCP) to the acute care facility. Jeff was diagnosed HIV positive 2 years ago. His history includes fatigue, a productive cough, and weight loss.

  23. Predictors of tuberculosis and human immunodeficiency virus co

    This case-control study was conducted in Tehran, Iran in June 2004, enrolling 2,388 HIV-positive people. Cases were selected from those who were co-infected with TB and controls from those without TB. Multiple logistic regression analysis was performed to assess the association between M. tuberculosis /HIV co-infection and several predictors.